Form 8-K - Current report:
SEC Accession No. 0001140361-19-021261
Filing Date
2019-11-22
Accepted
2019-11-22 17:17:02
Documents
17
Period of Report
2019-11-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form8k.htm   iXBRL 8-K 167088
2 ELEVENTH SUPPLEMENTAL INDENTURE ex4_1.htm EX-4.1 1686370
3 REGISTRATION RIGHTS AGREEMENT ex4_21.htm EX-4.21 126833
4 PRESS RELEASE OF BRISTOL-MYERS SQUIBB COMPANY ex99_1.htm EX-99.1 64225
9 image01.jpg GRAPHIC 16932
  Complete submission text file 0001140361-19-021261.txt   2663274

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bmy-20191121.xsd EX-101.SCH 5238
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmy-20191121_def.xml EX-101.DEF 19224
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmy-20191121_lab.xml EX-101.LAB 29813
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmy-20191121_pre.xml EX-101.PRE 21581
18 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 8537
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

EIN.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 191242508
SIC: 2834 Pharmaceutical Preparations